STAT3 and diabetic kidney disease: There is evidence that inhibiting stat3 activation in STZ-induced DKD can prevent the progression of fibrosis [26] and inhibited Stat3 signal can promote fatty acid oxidation and thus improve lipid accumulation in the liver.[27].